Provided by Tiger Fintech (Singapore) Pte. Ltd.

CureVac B.V.

3.19
-0.0200-0.62%
Post-market: 3.250.0600+1.88%19:52 EDT
Volume:325.13K
Turnover:1.04M
Market Cap:718.25M
PE:4.28
High:3.27
Open:3.24
Low:3.16
Close:3.21
Loading ...

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Simply Wall St.
·
23 Jan

Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab

Zacks
·
20 Jan

Moderna stock on track for 20% weekly gain after US bird flu death

Yahoo Finance
·
08 Jan

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Zacks
·
08 Jan

Vaccine Makers Rise Amid COVID/Flu Concerns; Novavax up 9%; Moderna up 7%

Tiger Newspress
·
08 Jan

Vaccine Stocks Jump on U.S. Bird-Flu Death -- WSJ

Dow Jones
·
08 Jan

Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand

GuruFocus.com
·
08 Jan

Vaccine Makers Rise Amid Bird Flu Vaccine Hope After First U.S. Death

Tiger Newspress
·
08 Jan

Cerus And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
28 Nov 2024

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Simply Wall St.
·
27 Nov 2024

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Zacks
·
21 Nov 2024

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Insider Monkey
·
20 Nov 2024

CureVac NV reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

GuruFocus.com
·
13 Nov 2024

CureVac Reports Surging Revenues and Profit Growth

TIPRANKS
·
13 Nov 2024

CureVac’s Financial Upsurge and Strategic Restructuring

TIPRANKS
·
13 Nov 2024

CureVac reports Q3 revenue EUR 493.9M vs. EUR 16.5M last year

TIPRANKS
·
12 Nov 2024

CureVac on track with 30% workforce reduction

TIPRANKS
·
12 Nov 2024

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

ACCESSWIRE
·
12 Nov 2024

CureVac Q3 Sales EUR493.90M Beat EUR103.76M Estimate; Represents 2,897% Increase From EUR 16.5M Prior Year

Benzinga
·
12 Nov 2024